Form 4: Oscar Health COO Steven Wolin Executes Stock Transactions Following Vesting of Equity Awards

Sentiment:

SEC Form 4


Oscar Health's Chief Operating Officer, Steven Wolin, engaged in multiple transactions involving Class A common stock, including the vesting of restricted stock units and subsequent sales to cover tax obligations.

Summary

  • Steven Wolin, the Chief Operating Officer of Oscar Health, Inc., reported several transactions involving the company's Class A common stock.
  • On December 1, 2024, Wolin acquired a total of 38,464 shares through the vesting of restricted stock units.
  • These restricted stock units vest over a three-year period in 12 equal quarterly installments, with different vesting start dates.
  • On December 2, 2024, Wolin sold 19,227 shares at a weighted average price of $18.07 and 353 shares at a weighted average price of $18.48.
  • These sales were executed to satisfy tax withholding obligations related to the vesting of the equity awards.
  • Following these transactions, Wolin directly owns 102,598 shares of Class A common stock and 144,863 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects routine insider transactions, which are neither positive nor negative in themselves. The sales are explicitly for tax obligations, which is a common practice.

Risks

  • The sale of shares by a company executive could be perceived negatively by the market, although these sales were explicitly for tax obligations.
  • Fluctuations in the stock price could impact the value of Wolin's remaining holdings.

Industry Context

This is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

  • The vesting and subsequent sale of shares to cover tax obligations is a standard practice among executives at publicly traded companies.
  • Similar transactions are regularly reported by executives at comparable companies in the health insurance sector, such as UnitedHealth Group (UNH) and Cigna (CI).

Stakeholder Impact

  • The transactions may have a minor impact on shareholders, as the sales by an executive could be perceived negatively, although they are for tax obligations.
  • The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
12/01/2024Date of restricted stock unit vesting and acquisition of Class A common stock.
12/02/2024Date of sale of Class A common stock.
12/03/2024Date of filing of the SEC Form 4.

Keywords

Oscar Health, Steven Wolin, Class A Common Stock, Restricted Stock Units, Equity Awards, SEC Form 4, Insider Trading, Stock Transactions, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.